Congenital heart diseases represent a diverse group of structural abnormalities present from birth, impacting the heart's functionality and circulation. These conditions, ranging from atrial septal defects to more complex anomalies like hypoplastic left heart syndrome, often require early intervention. Advances in diagnostic tools, such as fetal echocardiography and genetic screening, have enabled earlier detection and better planning of treatment strategies. Surgical innovations, including minimally invasive techniques and hybrid procedures, continue to improve survival rates. Additionally, the long-term management of congenital heart diseases focuses on preventing complications, ensuring that patients lead healthier, more active lives through comprehensive and personalized care.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation